Table 1.
Human Primary Cell Patient Characteristics
| Primary Prostate Epithelial Cells | |||||
|---|---|---|---|---|---|
| Cell ID | Pathology of Tissue Region | Age (Years) | Race | Shown in Figure | Organoid Growth |
| PrE-1 | Benign | 71 | AA | Figures 1, 2, 3, 4, and S1–S5 | ++++ |
| PrE-2 | Benign | 68 | AA | Figures 1, 3, S1, S4, and S5 | ++++ |
| PrE-3 | Benign | 58 | AA | Figures 5, S4, and S5 | ++ |
| PrECa-3 | Cancer 3 + 4 | Figures 5 and S4–S6 | +++ | ||
| PrE-4 | Benign | U | AA | Figures 5, S4, and S5 | ++ |
| PrECa-4 | Cancer 4 + 4 | Figures 5 and S4–S6 | ++ | ||
| PrE-5 | Benign | 60 | AA | Figures 5 and S4 | +++ |
| PrECa-5 | Cancer 3 + 3 | Figures 5, S4, and S6 | ++++ | ||
| PrE-6 | Benign | 57 | EA | Figures S4 and S5 | – |
| PrECa-6 | Cancer 4 + 4 | Figures S4–S6 | + | ||
| PrE-7 | Benign | 62 | EA | Figures S4 and S5 | – |
| PrECa-7 | Cancer 3 + 4 | Figures S4–S6 | ++ | ||
| Primary Prostate Stromal Cells | ||||
|---|---|---|---|---|
| Cell ID | Pathology of Tissue Region | Age | Race | Used in PrS Mix # |
| PrS-1 | Benign | 71 | AA | 3 |
| PrS-3 | Benign | 58 | AA | |
| PrS-8 | Benign | 64 | AA | 1, 2, 3 |
| PrS-9 | Benign | 60 | C | 1, 2, 3 |
| PrS-10 | Benign | 50 | AA | 1, 2 |
| PrS-11 | Benign | 55 | AA | 1 |
| PrS-12 | Benign | 71 | AA | 1 |
| PrS-13 | Benign | 61 | H | 2, 5, 6 |
| PrS-14 | Benign | 54 | U | 2 |
| PrS-15 | Benign | 63 | AA | 4 |
| PrS-16 | Benign | 61 | AA | 4 |
| PrS-17 | Benign | 73 | C | 4 |
| PrS-18 | Benign | 59 | AA | 4 |
| PrS-19 | Benign | 66 | AA | 6 |
| PrS-20 | Benign | 62 | U | 5, 6 |
PrS, primary stromal; PrE, primary epithelial; AA, African American; EA, European American; H, Hispanic; U, unavailable data.